1. Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model
- Author
-
Marwa Y. Issa, Mona K. Galal, Sherif H. Elmosalamy, Shimaa R. Emam, Bardes B. Hassan, Reham M. Abd-Elsalam, Shymaa A. El Badawy, Sara E. Ali, and Asmaa A. Azouz
- Subjects
medicine.medical_specialty ,endocrine system diseases ,Granulosa cell ,Gene Expression Regulation, Enzymologic ,Clomiphene ,03 medical and health sciences ,chemistry.chemical_compound ,Random Allocation ,0302 clinical medicine ,Lactation ,Internal medicine ,Drug Discovery ,medicine ,Animals ,Cholesterol Side-Chain Cleavage Enzyme ,030304 developmental biology ,Pharmacology ,0303 health sciences ,Dose-Response Relationship, Drug ,business.industry ,Aromatase Inhibitors ,Plant Extracts ,Letrozole ,Ovary ,Estrogen Antagonists ,Organ Size ,Isoflavones ,Polycystic ovary ,Cicer ,Rats ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Theca ,030220 oncology & carcinogenesis ,Phytoestrogens ,Female ,business ,Hormone ,medicine.drug ,Phytotherapy ,Polycystic Ovary Syndrome - Abstract
Ethnopharmacological relevance Chickpea was used in both greek and indian traditional medicine for hormonal related conditions as menstrual induction, acceleration of parturation, treatment of retained placenta and stimulation of lactation. Chickpea (Cicer arietinum) sprout isoflavone isolates exhibited reasonable estrogenic activities. Isoflavones, a subtype of phytoestrogens, are plant derivatives with moderate estrogenic activity that tend to have protective effects on hormonal and metabolic abnormalities of women with polycystic ovary syndrome (PCOS). Aim of the study In this study, we investigated the effect of UPLC/ESI-MS characterized Cicer arietinum L. seeds ethanol extract (CSE) on ovarian hormones, oxidative response and ovarian histological changes on induced PCOS rat model. Materials and methods Thirty-five rats were divided into five groups including negative control, PCOS, and treatment groups. PCOS was induced using letrozole (1 mg/kg) daily orally for 21 days. Each treatment group was treated with one of the following for 28 days after induction of PCOS: clomiphene citrate (1 mg/kg), and CSE at 250 and 500 mg/kg. Ovaries and uteri were excised, weighed and their sections were used for quantitative real-time reverse transcriptase polymerase chain reaction, antioxidant assays and histomorphometric study of the ovaries. The antioxidant assays, histopathological examination, hormonal and metabolic profiles, and Cyp11a1(steroidogenic enzyme) mRNA expression were measured. Results In all treatment groups, ovarian weight was significantly decreased despite having no significant effect on uterine weight. Histomorphometric study in the treatment groups revealed a significant decrease in the number and diameter of cystic follicles, a significant increase in granulosa cell thickness while, thickness of theca cells was significantly decreased when compared to PCOS. Hormone levels, metabolic profile and antioxidant status were improved in the treatment groups. Moreover, Cyp11a1 mRNA expression was significantly downregulated in the treatment groups compared to PCOS. Conclusions In the current study, CSE enhanced the reproductive and metabolic disorders which were associated with PCOS induction. For the first time, we have highlighted the effect of CSE in treating PCOS and its associated manifestations.
- Published
- 2021